# Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs' Girdle

> **NCT00181025** · PHASE2 · UNKNOWN · sponsor: **Gustave Roussy, Cancer Campus, Grand Paris** · enrollment: 33 (estimated)

## Conditions studied

- Sarcoma of Pelvis

## Interventions

- **DRUG:** Tasonermine (TNFa)
- **DRUG:** Melphalan

## Key facts

- **NCT ID:** NCT00181025
- **Lead sponsor:** Gustave Roussy, Cancer Campus, Grand Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-05
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 33 (ESTIMATED)
- **Last updated:** 2007-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00181025

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00181025, "Isolated Pelvic and Limb Perfusion in the Treatment of Locally Advanced Sarcoma of Pelvis and Limbs' Girdle". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00181025. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*